New Insights into the Role of Podoplanin in Epithelial-Mesenchymal Transition

International Review of Cell and Molecular Biology

Volumn 317, Issue , 2015, Pages 185-239

  Renart, Jaime ^a   Carrasco Ramírez, Patricia ^a   Fernández Muñoz, Beatriz ^b   Martín Villar, Ester ^a   Montero, Lucía ^a   Yurrita, María M ^a   Quintanilla, Miguel ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b Laboratorio Andaluz de Reprogramación Celular   (Spain)

Author keywords

Actin cytoskeleton; Cancer; CD44; Cell motility; Cell signaling; CLEC 2; ERM; Protein protein interactions

Indexed keywords

GALECTIN 8; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN A9; HERMES ANTIGEN; LECTIN; MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; PODOPLANIN; PROTEIN CLEC 2; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; TETRASPANIN; TETRASPANIN CD9; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; GP38 PROTEIN, MOUSE; PDPN PROTEIN, HUMAN;

BINDING SITE; BIOCHEMISTRY; CELL DENSITY; CELL INVASION; CELL MIGRATION; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; GENE STRUCTURE; GLYCOSYLATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEOPLASM; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; PROTEIN STRUCTURE; STROMA; TISSUE DISTRIBUTION; TUMOR CELL LINE; TUMOR GROWTH; ADULT; ANIMAL; CELL MOTION; METABOLISM; PATHOLOGY;

ADULT; ANIMALS; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASMS;

EID: 84925264401     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2015.01.009     Document Type: Article

References (266)

1. Abtahian F., Guerriero A., Sebzda E., Lu M.M., Zhou R., Mocsai A., Myers E.E., Huang B., Jackson D.G., Ferrari V.A., Tybulewicz V., Lowell C.A., Lepore J.J., Koretzky G.A., Kahn M.L. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003, 299(5604):247-251.
2. Acloque H., Adams M.S., Fishwick K., Bronner-Fraser M., Nieto M.A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J. Clin. Invest. 2009, 119(6):1438-1449.
3. Acton S.E., Astarita J.L., Malhotra D., Lukacs-Kornek V., Franz B., Hess P.R., Jakus Z., Kuligowski M., Fletcher A.L., Elpek K.G., Bellemare-Pelletier A., Sceats L., Reynoso E.D., Gonzalez S.F., Graham D.B., Chang J., Peters A., Woodruff M., Kim Y.A., Swat W., Morita T., Kuchroo V., Carroll M.C., Kahn M.L., Wucherpfennig K.W., Turley S.J. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity 2012, 37(2):276-289.
4. Acton S.E., Farrugia A.J., Astarita J.L., Mourao-Sa D., Jenkins R.P., Nye E., Hooper S., van Blijswijk J., Rogers N.C., Snelgrove K.J., Rosewell I., Moita L.F., Stamp G., Turley S.J., Sahai E., Reis e Sousa C. Dendritic cells control fibroblastic reticular network tension and lymph node expansion. Nature 2014, 514(7523):498-502.
5. Adhikary A., Chakraborty S., Mazumdar M., Ghosh S., Mukherjee S., Manna A., Mohanty S., Nakka K.K., Joshi S., De A., Chattopadhyay S., Sa G., Das T. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin Degradation: dual role of scaffold/matrix attachment region-binding protein 1 (smar1) in breast cancer cells. J. Biol. Chem. 2014, 289(37):25431-25444.
6. Aishima S., Nishihara Y., Iguchi T., et al. Mod. Pathol. 2008, 21:256-264.
7. Al-Rawi M.A., Watkins G., Mansel R.E., Jiang W.G. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells. Int. J. Oncol. 2005, 27(3):721-730.
8. Allen M., Jones J.L. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol. 2011, 223:162-176.
9. Antequera F. Structure, function and evolution of CpG island promoters. Cell. Mol. Life Sci. 2003, 60(8):1647-1658.
10. Ariizumi T., Ogose A., Kawashima H., Hotta T., Li G., Xu Y., Umezu H., Sugai M., Endo N. Pathol. Int. 2010, 60:193-202.
11. Arpin M., Chirivino D., Naba A., Zwaenepoel I. Emerging role for ERM proteins in cell adhesion and migration. Cell Adh. Migr. 2011, 5(2):199-206.
12. Astarita J.L., Cremasco V., Fu J., Darnell M.C., Peck J.R., Nieves-Bonilla J.M., Song K., Kondo Y., Woodruff M.C., Gogineni A., Onder L., Ludewig B., Weimer R.M., Carroll M.C., Mooney D.J., Xia L., Turley S.J. The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture. Nat. Immunol. 2015, 16(1):75-84.
13. Atsumi N., Ishii G., Kojima M., Sanada M., Fujii S., Ochiai A. Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431. Biochem. Biophys. Res. Commun. 2008, 373(1):36-41.
14. Barth K., Blasche R., Kasper M. T1alpha/podoplanin shows raft-associated distribution in mouse lung alveolar epithelial E10 cells. Cell. Physiol. Biochem. 2010, 25(1):103-112.
15. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell. Biol. 2000, 2(2):84-89.
16. Bianchi R., Fischer E., Yuen D., Ernst E., Ochsenbein A.M., Chen L., Otto V.I., Detmar M. Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity. J. Biol. Chem. 2014, 289(30):21016-21027.
17. Bissell M.J., Hall H.G., Parry G. How does the extracellular matrix direct gene expression?. J. Theor. Biol. 1982, 99(1):31-68.
18. Bonavida B., Baritaki S. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-kappaB/Snail/YY1/RKIP/PTEN Circuitry. Crit. Rev. Oncog. 2011, 16(3-4):211-226.
19. Boulter E., Estrach S., Garcia-Mata R., Feral C.C. Off the beaten paths: alternative and crosstalk regulation of Rho GTPases. FASEB J. 2012, 26(2):469-479.
20. Boumahdi S., Driessens G., Lapouge G., Rorive S., Nassar D., Le Mercier M., Delatte B., Caauwe A., Lenglez S., Nkusi E., Brohee S., Salmon I., Dubois C., Marmol V.d., Fuks F., Beck B., Blanpain C. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 2014, 511(7508):246-250.
21. Bourguignon L.Y.W. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin. Cancer Biol. 2008, 18(4):251-259.
22. Breiteneder-Geleff S., Matsui K., Soleiman A., Meraner P., Poczewski H., Kalt R., Schaffner G., Kerjaschki D. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J. Pathol. 1997, 151(4):1141-1152.
23. Breiteneder-Geleff S., Soleiman A., Kowalski H., Horvat R., Amann G., Kriehuber E., Diem K., Weninger W., Tschachler E., Alitalo K., Kerjaschki D. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 1999, 154(2):385-394.
24. Bretscher A., Edwards K., Fehon R.G. ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 2002, 3(8):586-599.
25. Brown L., Waseem A., Cruz I.N., Szary J., Gunic E., Mannan T., Unadkat M., Yang M., Valderrama F., O'Toole E.A., Wan H. Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation. Oncogene 2014, 33(18):2363-2374.
26. Bucala R. Inflammation & fibrosis: fibrocytes and fibrosis. QJM 2012, 105(6):505-508.
27. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2(2):76-83.
28. Carvalho F.M., Zaganelli F.L., Almeida B.G., Goes J.C., Baracat E.C., Carvalho J.P. Prognostic value of podoplanin expression in intratumoral stroma and neoplastic cells of uterine cervical carcinomas. Clinics (Sao Paulo) 2010, 65(12):1279-1283.
29. Colonna M., Samaridis J., Angman L. Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells. Eur. J. Immunol. 2000, 30(2):697-704.
30. Comerford I., Harata-Lee Y., Bunting M.D., Gregor C., Kara E.E., McColl S.R. A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system. Cytokine Growth Factor Rev. 2013, 24(3):269-283.
31. Cortez M.A., Nicoloso M.S., Shimizu M., Rossi S., Gopisetty G., Molina J.R., Carlotti C., Tirapelli D., Neder L., Brassesco M.S., Scrideli C.A., Tone L.G., Georgescu M.M., Zhang W., Puduvalli V., Calin G.A. miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes Chromosomes Cancer 2010, 49(11):981-990.
32. Cueni L.N., Detmar M. Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions. Exp. Cell Res. 2009, 315(10):1715-1723.
33. Cueni L.N., Hegyi I., Shin J.W., Albinger-Hegyi A., Gruber S., et al. Am. J. Pathol. 2010, 177:1004-1016.
34. Chanrion M., Kuperstein I., Barriere C., El Marjou F., Cohen D., Vignjevic D., Stimmer L., Paul-Gilloteaux P., Bieche I., Tavares Sdos R., Boccia G.F., Cacheux W., Meseure D., Fre S., Martignetti L., Legoix-Ne P., Girard E., Fetler L., Barillot E., Louvard D., Zinovyev A., Robine S. Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut. Nat. Commun. 2014, 5:5005.
35. Chen X., Cheng H., Pan T., Liu Y., Su Y., Ren C., Huang D., Zha X., Liang C. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer. Mol. Carcinog. 2014, 10.1002/mc.22177.
36. Christiansen J.J., Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006, 66(17):8319-8326.
37. Chu A.Y., Litzky L.A., Pasha T.L., et al. Mod. Pathol. 2005, 18:105-110.
38. Diaz-Lopez A., Moreno-Bueno G., Cano A. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag. Res. 2014, 6:205-216.
39. Dong S., Zhao J., Wei J., Bowser R., Khoo A., Liu Z., Luketich J., Pennathur A., Ma H., Zhao Y. F-box protein complex FBXL19 regulates TGFbeta1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation. Mol. Cancer 2014, 13(1):76.
40. Douglas Y.L., Mahtab E.A., Jongbloed M.R., Uhrin P., Zaujec J., Binder B.R., Schalij M.J., Poelmann R.E., Deruiter M.C., Gittenberger-de Groot A.C. Pulmonary vein, dorsal atrial wall and atrial septum abnormalities in podoplanin knockout mice with disturbed posterior heart field contribution. Pediatr. Res. 2009, 65(1):27-32.
41. Dumoff K.L., Chu C., Xu X., Pasha T., Zhang P.J., Acs G. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod. Pathol. 2005, 18(1):97-104.
42. Dumoff K.L., Chu C.S., Harris E.E., Holtz D., Xu X., Zhang P.J., Acs G. Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation. Mod. Pathol. 2006, 19(5):708-716.
43. Durchdewald M., Guinea-Viniegra J., Haag D., Riehl A., Lichter P., Hahn M., Wagner E.F., Angel P., Hess J. Podoplanin is a novel fos target gene in skin carcinogenesis. Cancer Res. 2008, 68(17):6877-6883.
44. Ekwall A.K., Eisler T., Anderberg C., Jin C., Karlsson N., Brisslert M., Bokarewa M.I. The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis. Arthritis Res. Ther. 2011, 13(2):R40.
45. Elsir T., Smits A., Lindstrom M.S., Nister M. Transcription factor PROX1: its role in development and cancer. Cancer Metastasis Rev. 2012, 31(3-4):793-805.
46. Ellis S., Mellor H. The novel Rho-family GTPase rif regulates coordinated actin-based membrane rearrangements. Curr. Biol. 2000, 10(21):1387-1390.
47. Engl W., Arasi B., Yap L.L., Thiery J.P., Viasnoff V. Actin dynamics modulate mechanosensitive immobilization of E-cadherin at adherens junctions. Nat. Cell Biol. 2014, 16(6):587-594.
48. Erez N., Truitt M., Olson P., Arron S.T., Hanahan D. Cancer-Associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17(2):135-147.
49. Espada J., Peinado H., Lopez-Serra L., Setien F., Lopez-Serra P., Portela A., Renart J., Carrasco E., Calvo M., Juarranz A., Cano A., Esteller M. Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context. Nucleic Acids Res. 2011, 39(21):9194-9205.
50. Ewald A.J., Huebner R.J., Palsdottir H., Lee J.K., Perez M.J., Jorgens D.M., Tauscher A.N., Cheung K.J., Werb Z., Auer M. Mammary collective cell migration involves transient loss of epithelial features and individual cell migration within the epithelium. J. Cell Sci. 2012, 125(Pt 11):2638-2654.
51. Farr A.G., Berry M.L., Kim A., Nelson A.J., Welch M.P., Aruffo A. Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues. J. Exp. Med. 1992, 176(5):1477-1482.
52. Fayngerts S.A., Wu J., Oxley C.L., Liu X., Vourekas A., Cathopoulis T., Wang Z., Cui J., Liu S., Sun H., Lemmon M.A., Zhang L., Shi Y., Chen Y.H. TIPE3 is the transfer protein of lipid second messengers that promote cancer. Cancer Cell 2014, 26(4):465-478.
53. Fehon R.G., McClatchey A.I., Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat. Rev. Mol. Cell Biol. 2010, 11(4):276-287.
54. Fei M., Zhou L., Xie J., Ruan Y., Xu J., He S., Shen H., Hu Y., Ren S., Ruan C. The production of soluble C-type lectin-like receptor 2 is a regulated process. Glycoconj J. 2012, 29(5-6):315-321.
55. Fernández-Muñoz B. Podoplanin Association with CD44 and Lipid Rafts: Relevance for the Regulation of Cell Motility and Epithelial Plasticity 2010, (Ph.D. thesis), Universidad Autónoma de Madrid, Madrid.
56. Fernández-Muñoz B., Yurrita M.M., Martin-Villar E., Carrasco-Ramirez P., Megias D., Renart J., Quintanilla M. The transmembrane domain of podoplanin is required for its association with lipid rafts and the induction of epithelial-mesenchymal transition. Int. J. Biochem. Cell Biol. 2011, 43(6):886-896.
57. Fernando R.I., Litzinger M., Trono P., Hamilton D.H., Schlom J., Palena C. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J. Clin. Invest. 2010, 120(2):533-544.
58. Friedl P., Wolf K., Zegers M.M. Rho-directed forces in collective migration. Nat. Cell Biol. 2014, 16(3):208-210.
59. Fu J., Gerhardt H., McDaniel J.M., Xia B., Liu X., Ivanciu L., Ny A., Hermans K., Silasi-Mansat R., McGee S., Nye E., Ju T., Ramirez M.I., Carmeliet P., Cummings R.D., Lupu F., Xia L. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J. Clin. Invest. 2008, 118(11):3725-3737.
60. Fukunaga M. Histopathology 2005, 46:396-402.
61. Fuller G.L.J., Williams J.A.E., Tomlinson M.G., Eble J.A., Hanna S.L., Pöhlmann S., Suzuki-Inoue K., Ozaki Y., Watson S.P., Pearce A.C. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J. Biol. Chem. 2007, 282:12397-12409.
62. Gandarillas A., Scholl F.G., Benito N., Gamallo C., Quintanilla M. Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis. Mol. Carcinog. 1997, 20(1):10-18.
63. Giampieri S., Manning C., Hooper S., Jones L., Hill C.S., Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol. 2009, 11(11):1287-1296.
64. Gingold J.A., Fidalgo M., Guallar D., Lau Z., Sun Z., Zhou H., Faiola F., Huang X., Lee D.F., Waghray A., Schaniel C., Felsenfeld D.P., Lemischka I.R., Wang J. A genome-wide RNAi screen identifies opposing functions of Snai1 and Snai2 on the Nanog dependency in reprogramming. Mol. Cell 2014, 56(1):140-152.
65. Gittenberger-de Groot A.C., Mahtab E.A., Hahurij N.D., Wisse L.J., Deruiter M.C., Wijffels M.C., Poelmann R.E. Nkx2.5-negative myocardium of the posterior heart field and its correlation with podoplanin expression in cells from the developing cardiac pacemaking and conduction system. Anat. Rec. (Hoboken) 2007, 290(1):115-122.
66. Goh W.I., Sudhaharan T., Lim K.B., Sem K.P., Lau C.L., Ahmed S. Rif-mDia1 interaction is involved in Filopodium formation independent of Cdc42 and rac effectors. J. Biol. Chem. 2011, 286(15):13681-13694.
67. Gonzalez D.M., Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci. Signal. 2014, 7(344):re8.
68. Gotzmann J., Mikula M., Eger A., Schulte-Hermann R., Foisner R., Beug H., Mikulits W. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat. Res. 2004, 566(1):9-20.
69. Groger M., Loewe R., Holnthoner W., Embacher R., Pillinger M., Herron G.S., Wolff K., Petzelbauer P. IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. J. Immunol. 2004, 173(12):7161-7169.
70. Gueron G., Giudice J., Valacco P., Paez A., Elguero B., Toscani M., Jaworski F., Leskow F.C., Cotignola J., Marti M., Binaghi M., Navone N., Vazquez E. Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cells. Oncotarget 2014, 5(12):4087-4102.
71. Guilluy C., Garcia-Mata R., Burridge K. Rho protein crosstalk: another social network?. Trends Cell Biol. 2011, 21(12):718-726.
72. Gulhati P., Bowen K.A., Liu J., Stevens P.D., Rychahou P.G., Chen M., Lee E.Y., Weiss H.L., O'Connor K.L., Gao T., Evers B.M. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 2011, 71(9):3246-3256.
73. Hamabe A., Konno M., Tanuma N., Shima H., Tsunekuni K., Kawamoto K., Nishida N., Koseki J., Mimori K., Gotoh N., Yamamoto H., Doki Y., Mori M., Ishii H. Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition. Proc. Natl. Acad. Sci. U.S.A. 2014, 111(43):15526-15531.
74. Hamada K., Shimizu T., Yonemura S., Tsukita S., Tsukita S., Hakoshima T. Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex. EMBO J. 2003, 22(3):502-514.
75. Hansen T., Kirkpatrick C.J. Oral Maxillofac. Surg. 2010, 14:223-226.
76. Hantusch B., Kalt R., Krieger S., Puri C., Kerjaschki D. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. BMC Mol. Biol. 2007, 8:20.
77. Hartsock A., Nelson W.J. Competitive regulation of E-cadherin JuxtaMembrane domain degradation by p120-catenin binding and Hakai-mediated ubiquitination. PLoS One 2012, 7(5):e37476.
78. Hemler M.E. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 2005, 6(10):801-811.
79. Hemler M.E. Tetraspanin proteins promote multiple cancer stages. Nat. Rev. Cancer 2013, 14(1):49-60.
80. Hong Y.K., Harvey N., Noh Y.H., Schacht V., Hirakawa S., Detmar M., Oliver G. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 2002, 225(3):351-357.
81. Honma M., Minami-Hori M., Takahashi H., Iizuka H. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-beta and STAT-3 activating cytokines, IFN-gamma, IL-6, and IL-22. J. Dermatol. Sci. 2012, 65(2):134-140.
82. Horiguchi K., Shirakihara T., Nakano A., Imamura T., Miyazono K., Saitoh M. Role of ras signaling in the induction of snail by transforming growth factor-β. J. Biol. Chem. 2009, 284(1):245-253.
83. Hsu D.S., Wang H.J., Tai S.K., Chou C.H., Hsieh C.H., Chiu P.H., Chen N.J., Yang M.H. Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages. Cancer Cell 2014, 26(4):534-548.
84. Hu Y., Yang Q., McMahon L.A., Wang H.L., Xu H. Appl. Immunohistochem. Mol. Morphol. 2010, 18:411-413.
85. Huang B., Lu M., Jolly M.K., Tsarfaty I., Onuchic J., Ben-Jacob E. The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition. Sci. Rep. 2014, 4:6449.
86. Huang K., Fingar D.C. Growing knowledge of the mTOR signaling network. Semin. Cell Dev. Biol. 2014, 36C:79-90.
87. Hughes R.C. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim. Biophys. Acta 1999, 1473(1):172-185.
88. Huse J.T., Pasha T.L., Zhang P.J. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma. Acta Neuropathol. 2007, 113(1):87-94.
89. Hwang Y.S., Xianglan Z., Park K.K., Chung W.Y. Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression. Carcinogenesis 2012, 33(11):2135-2146.
90. Insel P.A., Murray F., Yokoyama U., Romano S., Yun H., Brown L., Snead A., Lu D., Aroonsakool N. cAMP and Epac in the regulation of tissue fibrosis. Br. J. Pharmacol. 2012, 166(2):447-456.
91. Ito T., Ishii G., Nagai K., Nagano T., Kojika M., Murata Y., Atsumi N., Nishiwaki Y., Miyazaki E., Kumamoto T., Ochiai A. Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies. Lung Cancer 2009, 63(3):418-424.
92. Iwasaki T., Takeda Y., Maruyama K., Yokosaki Y., Tsujino K., Tetsumoto S., Kuhara H., Nakanishi K., Otani Y., Jin Y., Kohmo S., Hirata H., Takahashi R., Suzuki M., Inoue K., Nagatomo I., Goya S., Kijima T., Kumagai T., Tachibana I., Kawase I., Kumanogoh A. Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro. J. Biol. Chem. 2013, 288(4):2118-2131.
93. Jaffe A.B., Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 2005, 21:247-269.
94. Jiang L., Xiao L., Sugiura H., Huang X., Ali A., Kuro O.M., Deberardinis R.J., Boothman D.A. Metabolic reprogramming during TGFbeta1-induced epithelial-to-mesenchymal transition. Oncogene 2014, 10.1038/onc.2014.321.
95. Kadota K., Huang C.L., Liu D., et al. Lung Cancer 2010, 70:88-93.
96. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119(6):1420-1428.
97. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
98. Kaneko M.K., Kato Y., Kameyama A., Ito H., Kuno A., Hirabayashi J., Kubota T., Amano K., Chiba Y., Hasegawa Y., Sasagawa I., Mishima K., Narimatsu H. Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor. FEBS Lett. 2007, 581(2):331-336.
99. Kaneko M.K., Kato Y., Kitano T., Osawa M. Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor. Gene 2006, 378:52-57.
100. Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb. Perspect. Biol. 2009, 1(5):a000141.
101. Kato Y., Fujita N., Kunita A., Sato S., Kaneko M., Osawa M., Tsuruo T. Molecular identification of Aggrus/T1a as a platelet aggregation-inducing factor expressed in colorectal tumors. J. Biol. Chem. 2003, 278(51):51599-51605.
102. Kato Y., et al. Oncogene 2004, 23:8552-8556.
103. Kato Y., Kaneko M., Sata M., Fujita N., Tsuruo T., et al. Tumour Biol. 2005, 26:195-200.
104. Kato Y., Kaneko M.K. A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin. Sci. Rep. 2014, 4:5924.
105. Kawase A., Ishii G., Nagai K., Ito T., Nagano T., Murata Y., Hishida T., Nishimura M., Yoshida J., Suzuki K., Ochiai A. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int. J. Cancer 2008, 123(5):1053-1059.
106. Kenmotsu H., Ishii G., Nagai K., et al. Pathol. Int. 2008, 58(12):771-774.
107. Kerjaschki D., Regele H.M., Moosberger I., Nagy-Bojarski K., Watschinger B., Soleiman A., Birner P., Krieger S., Hovorka A., Silberhumer G., Laakkonen P., Petrova T., Langer B., Raab I. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 2004, 15:603-612.
108. Kim J., Bae S., An S., Park J.K., Kim E.M., Hwang S.G., Kim W.J., Um H.D. Cooperative actions of p21WAF1 and p53 induce slug protein degradation and suppress cell invasion. EMBO Rep. 2014, 15(10):1062-1068.
109. Kimura N., Kimura T. Pathol. Int. 2005, 55:83-86.
110. Kitano H., Kageyama S., Hewitt S.M., Hayashi R., Doki Y., Ozaki Y., Fujino S., Takikita M., Kubo H., Fukuoka J. Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival. Arch. Pathol. Lab. Med. 2010, 134(10):1520-1527.
111. Kizhatil K., Ryan M., Marchant J.K., Henrich S., John S.W.M. Schlemm's canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process. PLoS Biol. 2014, 12(7):e1001912.
112. Kotani M., Osanai T., Tajima Y., Kato H., Imada M., Kaneda H., Kubo H., Sakuraba H. Identification of neuronal cell lineage-specific molecules in the neuronal differentiation of P19 EC cells and mouse central nervous system. J. Neurosci. Res. 2002, 67(5):595-606.
113. Kotani M., Tajima Y., Osanai T., Irie A., Iwatsuki K., Kanai-Azuma M., Imada M., Kato H., Shitara H., Kubo H., Sakuraba H. Complementary DNA cloning and characterization of RANDAM-2, a type I membrane molecule specifically expressed on glutamatergic neuronal cells in the mouse cerebrum. J. Neurosci. Res. 2003, 73(5):603-613.
114. Kovalenko O.V., Metcalf D.G., DeGrado W.F., Hemler M.E. Structural organization and interactions of transmembrane domains in tetraspanin proteins. BMC Struct. Biol. 2005, 5:11.
115. Krishnan H., Ochoa-Alvarez J.A., Shen Y., Nevel E., Lakshminarayanan M., Williams M.C., Ramirez M.I., Miller W.T., Goldberg G.S. Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility. J. Biol. Chem. 2013, 288(17):12215-12221.
116. Lajer C.B., Garnaes E., Friis-Hansen L., Norrild B., Therkildsen M.H., Glud M., Rossing M., Lajer H., Svane D., Skotte L., Specht L., Buchwald C., Nielsen F.C. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br. J. Cancer 2012, 106(9):1526-1534.
117. Lamouille S., Xu J., Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014, 15(3):178-196.
118. Lee B., Villarreal-Ponce A., Fallahi M., Ovadia J., Sun P., Yu Q.C., Ito S., Sinha S., Nie Q., Dai X. Transcriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cells. Dev. Cell 2014, 29(1):47-58.
119. Lee K., Nelson C.M. New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis. Int. Rev. Cell Mol. Biol. 2012, 294:171-221.
120. Li R., Liang J., Ni S., Zhou T., Qing X., Li H., He W., Chen J., Li F., Zhuang Q., Qin B., Xu J., Li W., Yang J., Gan Y., Qin D., Feng S., Song H., Yang D., Zhang B., Zeng L., Lai L., Esteban M.A., Pei D. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010, 7(1):51-63.
121. Li X., Pei D., Zheng H. Transitions between epithelial and mesenchymal states during cell fate conversions. Protein Cell 2014, 5(8):580-591.
122. Liu X., Sun H., Qi J., Wang L., He S., Liu J., Feng C., Chen C., Li W., Guo Y., Qin D., Pan G., Chen J., Pei D., Zheng H. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat. Cell. Biol. 2013, 15(7):829-838.
123. Lombaerts M., van Wezel T., Philippo K., Dierssen J.W., Zimmerman R.M., Oosting J., van Eijk R., Eilers P.H., van de Water B., Cornelisse C.J., Cleton-Jansen A.M. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br. J. Cancer 2006, 94(5):661-671.
124. Lu M., Jolly M.K., Onuchic J., Ben-Jacob E. Toward decoding the principles of cancer metastasis circuits. Cancer Res. 2014, 74(17):4574-4587.
125. Lu M.H., Huang C.C., Pan M.R., Chen H.H., Hung W.C. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Clin. Cancer Res. 2012, 18(23):6416-6425.
126. Lunt S.Y., Vander Heiden M.G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 2011, 27(1):441-464.
127. Maeda M., Hasegawa H., Hyodo T., Ito S., Asano E., Yuang H., Funasaka K., Shimokata K., Hasegawa Y., Hamaguchi M., Senga T. ARHGAP18, a GTPase-activating protein for RhoA, controls cell shape, spreading, and motility. Mol. Biol. Cell 2011, 22(20):3840-3852.
128. Mahtab E.A., Vicente-Steijn R., Hahurij N.D., Jongbloed M.R., Wisse L.J., DeRuiter M.C., Uhrin P., Zaujec J., Binder B.R., Schalij M.J., Poelmann R.E., Gittenberger-de Groot A.C. Podoplanin deficient mice show a RhoA-related hypoplasia of the sinus venosus myocardium including the sinoatrial node. Dev. Dyn. 2009, 238(1):183-193.
129. Mahtab E.A., Wijffels M.C., Van Den Akker N.M., Hahurij N.D., Lie-Venema H., Wisse L.J., Deruiter M.C., Uhrin P., Zaujec J., Binder B.R., Schalij M.J., Poelmann R.E., Gittenberger-De Groot A.C. Cardiac malformations and myocardial abnormalities in podoplanin knockout mouse embryos: correlation with abnormal epicardial development. Dev. Dyn. 2008, 237(3):847-857.
130. Mäkinen T., Norrmén C., Petrova T. Molecular mechanisms of lymphatic vascular development. Cell. Mol. Life Sci. 2007, 64(15):1915-1929.
131. Marjoram R.J., Lessey E.C., Burridge K. Regulation of RhoA activity by adhesion molecules and mechanotransduction. Curr. Mol. Med. 2014, 14(2):199-208.
132. Marks A., Sutherland D.R., Bailey D., Iglesias J., Law J., Lei M., Yeger H., Banerjee D., Baumal R. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br. J. Cancer 1999, 80(3-4):569-578.
133. Martin-Villar E., Fernandez-Munoz B., Parsons M., Yurrita M.M., Megias D., Perez-Gomez E., Jones G.E., Quintanilla M. Podoplanin associates with CD44 to promote directional cell migration. Mol. Biol. Cell 2010, 21(24):4387-4399.
134. Martín-Villar E., Megias D., Castel S., Yurrita M.M., Vilaro S., Quintanilla M. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J. Cell Sci. 2006, 119:4541-4553.
135. Martin-Villar E., Scholl F.G., Gamallo C., Yurrita M.M., Munoz-Guerra M., Cruces J., Quintanilla M. Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int. J. Cancer 2005, 113(6):899-910.
136. Martin-Villar E., Yurrita M.M., Fernandez-Munoz B., Quintanilla M., Renart J. Regulation of podoplanin/PA2.26 antigen expression in tumour cells. Involvement of calpain-mediated proteolysis. Int. J. Biochem. Cell Biol. 2009, 41(6):1421-1429.
137. Martín-Villar M., Borda-d'Agua B., Carrasco-Ramirez P., Renart J., Quintanilla M., Jones G.E. Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability. Oncogene 2014, 10.1038/onc.2014.388.
138. Massague J. TGFbeta in Cancer. Cell 2008, 134(2):215-230.
139. McGrail D.J., Mezencev R., Kieu Q.M., McDonald J.F., Dawson M.R. SNAIL-induced epithelial-to-mesenchymal transition produces concerted biophysical changes from altered cytoskeletal gene expression. FASEB J. 2014, 10.1096/fj.14-257345.
140. Mei Y., Zhang P., Zuo H., Clark D., Xia R., Li J., Liu Z., Mao L. Ebp1 activates podoplanin expression and contributes to oral tumorigenesis. Oncogene 2014, 33(29):3839-3850.
141. Mishima K., Kato Y., Kaneko M.K., et al. Acta Neuropathol. 2006, 111:483-488.
142. Mishima K., Kato Y., Kaneko M.K., et al. Acta Neuropathol. 2006, 111:563-568.
143. Moll R., Divo M., Langbein L. The human keratins: biology and pathology. Histochem. Cell Biol. 2008, 129(6):705-733.
144. Moreno-Bueno G., Portillo F., Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008, 27(55):6958-6969.
145. Morita T., Mayanagi T., Sobue K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J. Cell Biol. 2007, 179(5):1027-1042.
146. Murali A., Rajalingam K. Small Rho GTPases in the control of cell shape and mobility. Cell. Mol. Life Sci. 2014, 71(9):1703-1721.
147. Nagae M., Morita-Matsumoto K., Kato M., Kaneko M.K., Kato Y., Yamaguchi Y. A platform of c-type lectin-like receptor CLEC-2 for binding o-glycosylated podoplanin and Nonglycosylated rhodocytin. Structure 2014, 22(12):1711-1721.
148. Nagano O., Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci. 2004, 95(12):930-935.
149. Nakazawa Y., Sato S., Naito M., Kato Y., Mishima K., Arai H., Tsuruo T., Fujita N. Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis. Blood 2008, 112(5):1730-1739.
150. Navarro-Nunez L., Langan S.A., Nash G.B., Watson S.P. The physiological and pathophysiological roles of platelet CLEC-2. Thromb. Haemost. 2013, 109(6):991-998.
151. Naqvi J., Ordonez N.G., Luna M.A., et al. Head Neck Pathol. 2008, 2:25-30.
152. Neisch A.L., Formstecher E., Fehon R.G. Conundrum, an ARHGAP18 orthologue, regulates RhoA and proliferation through interactions with Moesin. Mol. Biol. Cell 2013, 24(9):1420-1433.
153. Neulen M.-L., Göbel T.W. Identification of a chicken CLEC-2 homologue, an activating C-type lectin expressed by thrombocytes. Immunogenetics 2012, 64:389-397.
154. Nieto M.A. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu. Rev. Cell Dev. Biol. 2011, 27:347-376.
155. Nieto M.A. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 2013, 342(6159):1234850.
156. Nieto M.A., Cano A. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin. Cancer Biol. 2012, 22(5-6):361-368.
157. Nose K., Saito H., Kuroki T. Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Cell Growth Differ. 1990, 1(11):511-518.
158. Ohizumi I., Harada N., Taniguchi K., Tsutsumi Y., Nakagawa S., Kaiho S., Mayumi T. Association of CD44 with OTS-8 in tumor vascular endothelial cells. Biochim. Biophys. Acta 2000, 1497(2):197-203.
159. Okamoto I., Kawano Y., Murakami D., Sasayama T., Araki N., Miki T., Wong A.J., Saya H. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 2001, 155(5):755-762.
160. Olson E.N., Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat. Rev. Mol. Cell Biol. 2010, 11(5):353-365.
161. Ordonez N.G. Podoplanin: a novel diagnostic immunohistochemical marker. Adv. Anat. Pathol. 2006, 13(2):83-88.
162. Orgaz J.L., Pandya P., Dalmeida R., Karagiannis P., Sanchez-Laorden B., Viros A., Albrengues J., Nestle F.O., Ridley A.J., Gaggioli C., Marais R., Karagiannis S.N., Sanz-Moreno V. Diverse matrix metalloproteinase functions regulate cancer amoeboid migration. Nat. Commun. 2014, 5:4255.
163. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121(3):335-348.
164. Ota I., Li X.Y., Hu Y., Weiss S.J. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(48):20318-20323.
165. Pan Y., Wang W.D., Yago T. Transcriptional regulation of podoplanin expression by Prox1 in lymphatic endothelial cells. Microvasc. Res. 2014, 94C:96-102.
166. Paz H., Pathak N., Yang J. Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene 2014, 33(33):4193-4202.
167. Pearson M.A., Reczek D., Bretscher A., Karplus P.A. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 2000, 101(3):259-270.
168. Peduto L., Dulauroy S., Lochner M., Spath G.F., Morales M.A., Cumano A., et al. J. Immunol. 2009, 182:5789-5799.
169. Peinado H., Ballestar E., Esteller M., Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol. 2004, 24(1):306-319.
170. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 2007, 7(6):415-428.
171. Peinado H., Quintanilla M., Cano A. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem. 2003, 278(23):21113-21123.
172. Peterziel H., Muller J., Danner A., Barbus S., Liu H.K., Radlwimmer B., Pietsch T., Lichter P., Schutz G., Hess J., Angel P. Expression of podoplanin in human astrocytic brain tumors is controlled by the PI3K-AKT-AP-1 signaling pathway and promoter methylation. Neuro Oncol. 2012, 14(4):426-439.
173. Petrie R.J., Yamada K.M. At the leading edge of three-dimensional cell migration. J. Cell Sci. 2012, 125(24):5917-5926.
174. Płaszczyca A., Nilsson J., Magnusson L., Brosjö O., Larsson O., Vult von Steyern F., Domanski H.A., Lilljebjörn H., Fioretos T., Tayebwa J., Mandahl N., Nord K.H., Mertens F. Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma. Int. J. Biochem. Cell Biol. 2014, 53(0):475-481.
175. Pollitt A.Y., Poulter N.S., Gitz E., Navarro-Nuñez L., Wang Y.J., Hughes C.E., Thomas S.G., Nieswandt B., Douglas M.R., Owen D.M., Jackson D.G., Dustin M.L., Watson S.P. Syk and Src family kinases regulate CLEC-2 mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells. J. Biol. Chem. 2014, 289(52):35695-35710.
176. Priya R., Yap A.S., Gomez G.A. E-cadherin supports steady-state Rho signaling at the epithelial zonula adherens. Differentiation 2013, 86(3):133-140.
177. Pujuguet P., Del Maestro L., Gautreau A., Louvard D., Arpin M. Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol. Biol. Cell 2003, 14(5):2181-2191.
178. Pula B., Jethon A., Piotrowska A., Gomulkiewicz A., Owczarek T., Calik J., Wojnar A., Witkiewicz W., Rys J., Ugorski M., Dziegiel P., Podhorska-Okolow M. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. Histopathology 2011, 59(6):1249-1260.
179. Pula B., Witkiewicz W., Dziegiel P., Podhorska-Okolow M. Significance of podoplanin expression in cancer-associated fibroblasts: a comprehensive review. Int. J. Oncol. 2013, 42(6):1849-1857.
180. Ragusa S., Cheng J., Ivanov K.I., Zangger N., Ceteci F., Bernier-Latmani J., Milatos S., Joseph J.M., Tercier S., Bouzourene H., Bosman F.T., Letovanec I., Marra G., Gonzalez M., Cammareri P., Sansom O.J., Delorenzi M., Petrova T.V. PROX1 promotes metabolic adaptation and fuels outgrowth of wnt metastatic colon cancer cells. Cell Rep. 2014, 8:1957-1973.
181. Ramirez M.I., Millien G., Hinds A., Cao Y., Seldin D.C., Williams M.C. T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev. Biol. 2003, 256(1):61-72.
182. Ramirez M.I., Rishi A.K., Cao Y.X., Williams M.C. TGT3, thyroid transcription factor I, and Sp1 elements regulate transcriptional activity of the 1.3-kilobase pair promoter of T1alpha, a lung alveolar type I cell gene. J. Biol. Chem. 1997, 272(42):26285-26294.
183. Ratheesh A., Priya R., Yap A.S. Coordinating Rho and Rac: the regulation of Rho GTPase signaling and cadherin junctions. Prog. Mol. Biol. Transl. Sci. 2013, 116:49-68.
184. Reeves R., Edberg D.D., Li Y. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 2001, 21(2):575-594.
185. Ren J., Wen L., Gao X., Jin C., Xue Y., Yao X. DOG 1.0: illustrator of protein domain structures. Cell Res. 2009, 19(2):271-273.
186. Riganti C., Castella B., Kopecka J., Campia I., Coscia M., Pescarmona G., Bosia A., Ghigo D., Massaia M. Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells. PLoS One 2013, 8(4):e60975.
187. Rishi A.K., Joyce-Brady M., Fisher J., Dobbs L.G., Floros J., VanderSpek J., Brody J.S., Williams M.C. Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives. Dev. Biol. 1995, 167(1):294-306.
188. Rodrigo J.P., García-Carracedo D., González M.V., Mancebo G., Fresno M.F., García-Pedrero J. Mol. Cancer 2010, 9:48. 10.1186/1476-4598-9-48.
189. Rubin H. What keeps cells in tissues behaving normally in the face of myriad mutations?. BioEssays 2006, 28(5):515-524.
190. Rubin H. Contact interactions between cells that suppress neoplastic development: can they also explain metastatic dormancy?. Adv. Cancer Res. 2008, 100:159-202.
191. Russ W.P., Engelman D.M. The GxxxG motif: a framework for transmembrane helix-helix association. J. Mol. Biol. 2000, 296(3):911-919.
192. Sadok A., Marshall C.J. Rho GTPases: masters of cell migration. Small GTPases 2014, 5(1):e29710.
193. Sailer M.H., Gerber A., Tostado C., Hutter G., Cordier D., Mariani L., Ritz M.F. Non-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signaling. J. Cell Sci. 2013, 126(Pt 16):3533-3540.
194. Sarrió D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008, 68(4):989-997.
195. Schacht V., Ramirez M.I., Hong Y.K., Hirakawa S., Feng D., Harvey N., Williams M., Dvorak A.M., Dvorak H.F., Oliver G., Detmar M. T1a/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. Embo J. 2003, 22(14):3546-3556.
196. Schacht V., Dadras S.S., Johnson L.A., Jackson D.G., Hong Y.-K., Detmar M. Am. J. Pathol. 2005, 166:913-921.
197. Schietinger A., Philip M., Yoshida B.A., Azadi P., Liu H., Meredith S.C., Schreiber H. A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science 2006, 314(5797):304-308.
198. Scholl F.G., Gamallo C., Quintanilla M. Ectopic expression of PA2.26 antigen in epidermal keratinocytes leads to destabilization of adherens junctions and malignant progression. Lab. Invest. 2000, 80(11):1749-1759.
199. Scholl F.G., Gamallo C., Vilaró S., Quintanilla M. Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J. Cell Sci. 1999, 112(Pt 24):4601-4613.
200. Schoppmann S.F., Jesch B., Riegler M.F., Maroske F., Schwameis K., et al. Clin. Exp. Metastasis 2013, 30:441-446.
201. Sebzda E., Hibbard C., Sweeney S., Abtahian F., Bezman N., Clemens G., Maltzman J.S., Cheng L., Liu F., Turner M., Tybulewicz V., Koretzky G.A., Kahn M.L. Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev. Cell 2006, 11(3):349-361.
202. Shen Y., Chen C.S., Ichikawa H., Goldberg G.S. Src induces pdpn expression to promote cell migration. J. Biol. Chem. 2010, 285(13):9649-9656.
203. Shibahara J., Kashima T., Kikuchi Y., et al. Virchows Arch. 2006, 448:493-499.
204. Shimada Y., Ishii G., Nagai K., Atsumi N., Fujii S., Yamada A., Yamane Y., Hishida T., Nishimura M., Yoshida J., Ikeda N., Ochiai A. Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci. 2009, 100(11):2054-2059.
205. Shintaku M., Honda T., Sakai T. Brain Tumor Pathol. 2010, 27:23-27.
206. Smith A.L., Dohn M.R., Brown M.V., Reynolds A.B. Association of Rho-associated protein kinase 1 with E-cadherin complexes is mediated by p120-catenin. Mol. Biol. Cell 2012, 23(1):99-110.
207. Smith S.M., Melrose J. Podoplanin is expressed by a sub-population of human foetal rib and knee joint rudiment chondrocytes. Tissue Cell 2011, 43(1):39-44.
208. Song Y., Shen J., Lin Y., Shen J., Wu X., Yan Y., Zhou L., Zhang H., Zhou Y., Cao M., Liu Y. Up-regulation of podoplanin involves in neuronal apoptosis in LPS-induced neuroinflammation. Cell. Mol. Neurobiol. 2014, 34(6):839-849.
209. Sonne S.B., Herlihy A.S., Hoei-Hansen C.E., Nielsen J.E., Almstrup K., Skakkebaek N.E., Marks A., Leffers H., Rajpert-De Meyts E. Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours. Virchows Arch. 2006, 449(2):200-206.
210. Speck O., Hughes S.C., Noren N.K., Kulikauskas R.M., Fehon R.G. Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity. Nature 2003, 421(6918):83-87.
211. Springer G.F. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J. Mol. Med. 1997, 75(8):594-602.
212. Stelzl U., Worm U., Lalowski M., Haenig C., Brembeck F.H., Goehler H., Stroedicke M., Zenkner M., Schoenherr A., Koeppen S., Timm J., Mintzlaff S., Abraham C., Bock N., Kietzmann S., Goedde A., Toksöz E., Droege A., Krobitsch S., Korn B., Birchmeier W., Lehrach H., Wanker E.E. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122(6):957-968.
213. Sun Q., Zhang J., Cao W., Wang X., Xu Q., Yan M., Wu X., Chen W. Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int. J. Biochem. Cell Biol. 2013, 45(3):513-520.
214. Suzuki-Inoue K., Fuller G.L., Garcia A., Eble J.A., Pohlmann S., Inoue O., Gartner T.K., Hughan S.C., Pearce A.C., Laing G.D., Theakston R.D., Schweighoffer E., Zitzmann N., Morita T., Tybulewicz V.L., Ozaki Y., Watson S.P. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006, 107(2):542-549.
215. Suzuki-Inoue K., Inoue O., Ding G., Nishimura S., Hokamura K., Eto K., Kashiwagi H., Tomiyama Y., Yatomi Y., Umemura K., Shin Y., Hirashima M., Ozaki Y. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J. Biol. Chem. 2010, 285(32):24494-24507.
216. Suzuki-Inoue K., Kato Y., Inoue O., Kaneko M.K., Mishima K., Yatomi Y., Yamazaki Y., Narimatsu H., Ozaki Y. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J. Biol. Chem. 2007, 282(36):25993-26001.
217. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
218. Tammela T., Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010, 140(4):460-476.
219. Tan E.J., Kahata K., Idas O., Thuault S., Heldin C.H., Moustakas A. The high mobility group A2 protein epigenetically silences the Cdh1 gene during epithelial-to-mesenchymal transition. Nucleic Acids Res. 2014, 10.1093/nar/gku1293.
220. Terawaki S-i., Kitano K., Hakoshima T. Structural basis for type II membrane protein binding by ERM proteins revealed by the radixin-neutral endopeptidase 24.11 (NEP) complex. J. Biol. Chem. 2007, 282(27):19854-19862.
221. Terawaki S., Maesaki R., Hakoshima T. Structural basis for NHERF recognition by ERM proteins. Structure 2006, 14(4):777-789.
222. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139(5):871-890.
223. Thiery J.P., Engl W., Viasnoff V., Dufour S. Biochemical and biophysical origins of cadherin selectivity and adhesion strength. Curr. Opin. Cell Biol. 2012, 24(5):614-619.
224. de Toledo M., Anguille C., Roger L., Roux P., Gadea G. Cooperative anti-invasive effect of Cdc42/Rac1 activation and ROCK inhibition in SW620 colorectal cancer cells with elevated blebbing activity. PLoS One 2012, 7(11):e48344.
225. Tomooka M., et al. Acta Histochem. Cytochem. 2013, 46:171-177.
226. Toole B.P. Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin. Cancer Res. 2009, 15(24):7462-7468.
227. Toyoshima M., Nakajima M., Yamori T., Tsuruo T. Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26. Cancer Res. 1995, 55(4):767-773.
228. Tran D.D., Corsa C.A.S., Biswas H., Aft R.L., Longmore G.D. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol. Cancer Res. 2011, 9(12):1644-1657.
229. Tsuneki M., Maruyama S., Yamazaki M., Xu B., Essa A., Abe T., Babkair H., Cheng J., Yamamoto T., Saku T. Extracellular heat shock protein A9 is a novel interaction partner of podoplanin in oral squamous cell carcinoma cells. Biochem. Biophys. Res. Commun. 2013, 434(1):124-130.
230. Uhrin P., Zaujec J., Breuss J.M., Olcaydu D., Chrenek P., Stockinger H., Fuertbauer E., Moser M., Haiko P., Fassler R., Alitalo K., Binder B.R., Kerjaschki D. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010, 115(19):3997-4005.
231. Unternaehrer J.J., Zhao R., Kim K., Cesana M., Powers J.T., Ratanasirintrawoot S., Onder T., Shibue T., Weinberg R.A., Daley G.Q. The epithelial-mesenchymal transition factor SNAIL paradoxically enhances reprogramming. Stem Cell Rep. 2014, 3(5):691-698.
232. Vanderbilt J.N., Dobbs L.G. Characterization of the gene and promoter for RTI40, a differentiation marker of type I alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 1998, 19(4):662-671.
233. Wadhwa R., Taira K., Kaul S.C. An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?. Cell Stress Chaperones 2002, 7(3):309-316.
234. Wakisaka N., Yoshida S., Kondo S., Kita M., Sawada-Kitamura S., Endo K., Tsuji A., Nakanish Y., Murono S., Yoshizaki T. Induction of epithelial-mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma. Histopathology 2014, 10.1111/his.12496.
235. Ward P.L., Koeppen H., Hurteau T., Schreiber H. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J. Exp. Med. 1989, 170(1):217-232.
236. Warzecha C.C., Jiang P., Amirikian K., Dittmar K.A., Lu H., Shen S., Guo W., Xing Y., Carstens R.P. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J. 2010, 29(19):3286-3300.
237. Watanabe K., Villarreal-Ponce A., Sun P., Salmans M.L., Fallahi M., Andersen B., Dai X. Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. Dev. Cell 2014, 29(1):59-74.
238. Watanabe M., Okochi E., Sugimoto Y., Tsuruo T. Identification of a platelet-aggregating factor of murine colon adenocarcinoma 26: Mr 44,000 membrane protein as determined by monoclonal antibodies. Cancer Res. 1988, 48(22):6411-6416.
239. Watanabe M., Sugimoto Y., Tsuruo T. Expression of a Mr 41,000 glycoprotein associated with thrombin-independent platelet aggregation in high metastatic variants of murine B16 melanoma. Cancer Res. 1990, 50(20):6657-6662.
240. Wetterwald A., Hoffstetter W., Cecchini M.G., Lanske B., Wagner C., Fleisch H., Atkinson M. Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone 1996, 18(2):125-132.
241. Wicki A., Christofori G. Br. J. Cancer 2007, 96:1-5.
242. Wicki A., Lehembre F., Wick N., Hantusch B., Kerjaschki D., Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006, 9(4):261-272.
243. Wigle J.T., Harvey N., Detmar M., Lagutina I., Grosveld G., Gunn M.D., Jackson D.G., Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002, 21(7):1505-1513.
244. Wilhelm M., et al. Nature 2014, 509:582-587.
245. Williams M.C., Cao Y., Hinds A., Rishi A.K., Wetterwald A. T1 alpha protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus, and ciliary epithelia of adult rats. Am. J. Respir. Cell Mol. Biol. 1996, 14(6):577-585.
246. Witty A.D., Mihic A., Tam R.Y., Fisher S.A., Mikryukov A., Shoichet M.S., Li R.-K., Kattman S.J., Keller G. Generation of the epicardial lineage from human pluripotent stem cells. Nat. Biotechnol. 2014, 32(10):1026-1035.
247. Wu C.Y., Tsai Y.P., Wu M.Z., Teng S.C., Wu K.J. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet. 2012, 28(9):454-463.
248. Xie J., Wu T., Guo L., Ruan Y., Zhou L., Zhu H., Yun X., Hong Y., Jiang J., Wen Y., Gu J. Molecular characterization of two novel isoforms and a soluble form of mouse CLEC-2. Biochem. Biophys. Res. Commun. 2008, 371(2):180-184.
249. Xu M., Zhu C., Zhao X., Chen C., Zhang H., Yuan H., Deng R., Dou J., Wang Y., Huang J., Chen Q., Jiang B., Yu J. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget 2015, 6(2):979-994.
250. Yamanashi T., Nakanishi Y., Fujii G., Akishima Fukasawa Y., Moriya Y., Kanai Y., et al. Oncology 2009, 77:53-62.
251. Yanez-Mo M., Barreiro O., Gordon-Alonso M., Sala-Valdes M., Sanchez-Madrid F. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol. 2009, 19(9):434-446.
252. Yang J.-Y., Zong C.S., Xia W., Wei Y., Ali-Seyed M., Li Z., Broglio K., Berry D.A., Hung M.-C. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol. Cell. Biol. 2006, 26(19):7269-7282.
253. Yang H.M., Cabral E., Dadras S.S., Cassarino D.S. Am. J. Dermatopathol. 2008, 30:549-554.
254. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008, 14(6):818-829.
255. Yang S., Kim H.-M. ROCK inhibition activates MCF-7 cells. PLoS One 2014, 9(2):e88489.
256. Yonemura S., Hirao M., Doi Y., Takahashi N., Kondo T., Tsukita S., Tsukita S. Ezrin/Radixin/Moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J. Cell Biol. 1998, 140(4):885-895.
257. Yoshida T., Ishii G., Goto K., Neri S., Hashimoto H., Yoh K., Niho S., Umemura S., Matsumoto S., Ohmatsu H., Iida S., Niimi A., Nagai K., Ohe Y., Ochiai A. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation. Clin. Cancer Res. 2015, 21(3):642-651.
258. Yuan P., Temam S., El-Naggar A., Zhou X., Diane D., Liu M.S., Jack Lee J., Mao Li Cancer 2006, 107:563-569.
259. Yurrita M.M., Fernandez-Munoz B., Del Castillo G., Martin-Villar E., Renart J., Quintanilla M. Podoplanin is a substrate of presenilin-1/gamma-secretase. Int. J. Biochem. Cell Biol. 2014, 46:68-75.
260. Zavadil J., Narasimhan M., Blumenberg M., Schneider R.J. Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 2007, 185(1-3):157-161.
261. Zaveri H., Beck T., Hernández-García A., Shelly K., Montgomery T., van Haeringen A., Anderlid B.M., Patel S., Goe H., Houge G., Morrow B., Cheung S., Lalani S., Scott D. Identification of critical regions and candidate genes for cardiovascular malformations and cardiomyopathy associated with deletions of chromosome 1p36. PLoS One 2014, 9(1):e85600.
262. Zegers M.M., Friedl P. Rho GTPases in collective cell migration. Small GTPases 2014, 5(1):e28997.
263. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 2009, 119(6):1429-1437.
264. Ziegler E., Hansen M.T., Haase M., Emons G., Grundker C. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo. Breast Cancer Res. Treat. 2014, 148(2):269-277.
265. Zimmer G., Klenk H.D., Herrler G. Identification of a 40-kDa cell surface sialoglycoprotein with the characteristics of a major influenza C virus receptor in a Madin-Darby canine kidney cell line. J. Biol. Chem. 1995, 270(30):17815-17822.
266. Zimmer G., Lottspeich F., Maisner A., Klenk H.D., Herrler G. Molecular characterization of gp40, a mucin-type glycoprotein from the apical plasma membrane of Madin-Darby canine kidney cells (type I). Biochem. J. 1997, 326(Pt 1):99-108.